-
Selegiline, also
known as L-deprenyl and sold
under the
brand names Eldepryl, Zelapar, and
Emsam among others, is a
medication which is used in the treatment...
- brain.
Rasagiline shows pharmacological differences from the
related drug
selegiline,
including having no amphetamine-like metabolites, monoamine-releasing...
-
pharmacology of
selegiline pertains to the
pharmacodynamic and
pharmacokinetic properties of the
antiparkinsonian and
antidepressant selegiline (L-deprenyl)...
-
complicated by
panic disorder or
hysteroid dysphoria.
Newer MAOIs such as
selegiline (typically used in the
treatment of Parkinson's disease) and the reversible...
-
catecholamine releasing activity. It is 1- to 10-fold less
potent than
selegiline but is 3- to 5-fold more
potent than
dextromethamphetamine in this action...
- pseudoephedrine),
antidepressants (e.g. bupropion),
antiparkinson agents (e.g.,
selegiline), and
vasopressors (e.g., ephedrine),
among others. Many of
these psychoactive...
- the
developmental code name MK-306, is an
experimental drug
related to
selegiline which acts as a
catecholaminergic activity enhancer (CAE). PPAP is a CAE...
-
levoamphetamine is a
known active metabolite of
certain other drugs, such as
selegiline (L-deprenyl).
Levoamphetamine has been used in the
treatment of attention...
- phentermine, mephentermine, tranylcypromine, bupropion, methoxyphenamine,
selegiline,
amfepramone (diethylpropion), pyrovalerone, MDMA (ecstasy), and DOM (STP)...
-
similar potency. This is
similar to BPAP, but is in
contrast to PPAP and
selegiline,
which act
exclusively as
catecholaminergic activity enhancers (CAEs)...
